Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...

10x Genomics, Inc. (NASDAQ:TXG – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of 10x Genomics in a research note issued to investors on ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

The continued research in molecular diagnostics and genomics, along with the adoption of personalized medicine, further propels the growth of the WGA industry. The whole genome amplification market is ...

As discussed in my previous articles, MI350 will be powered by the next-generation of CDNA 4 architecture, delivering a 35x increase in AI computing performance compared to CDNA 3. During the ...